GRAIL

MENLO PARK, Calif., July 16, 2026 GRAIL, Inc. has announced a strategic collaboration with Priority Health, making the Galleri®...

CHICAGO, Illinois, May 31, 2026 Johnson & Johnson has reported pivotal results from the Phase 1b/2 OrigAMI-4 study, demonstrating...

MENLO PARK, California, May 31, 2026 GRAIL, Inc. has unveiled compelling new results from its registrational PATHFINDER 2 study,...